<DOC>
	<DOCNO>NCT02241681</DOCNO>
	<brief_summary>Medium Chain Triglycerides ( MCT ) use many year good source lipid decrease potential fat malabsorption . However , pharmacokinetics MCT metabolite explore detail . This exploratory study aim determine plasma level MCT metabolites oral intake Peptamen .</brief_summary>
	<brief_title>Medium Chain Triglycerides Plasma Profile Their Metabolites After Oral Peptamen Intake</brief_title>
	<detailed_description>20 subject give 250mL peptamen 1.5 twice , 4 hour interval , single day . Plasma kinetics MCTs metabolite make 8 hour baseline</detailed_description>
	<criteria>Healthy male female Aged 20 65 year old BMI normal range ( 18.5 25.0 kg/m2 ) Having sign his/her consent form Clinically relevant digestive ( include malabsorption major surgery ) , renal , hepatic , pancreatic metabolic disease ( diabetes , hypo hyperthyroidism , hypo hypercorticism ) , determine medical ( screen ) visit standard blood chemistry analysis ( glucose , total cholesterol , ALDL , AHDL , triglyceride , ASAT , ALTI , gamma GT , RCRP , creatinine ) Medically diagnose anemia base blood formula Food allergy , lactose intolerance intolerance milk protein ( anamnesis ) Smokers ( anamnesis ) Pregnancy ( anamnesis ) Under corticoid hormone ( adrenal , thyroid ) treatment Alcohol intake : &gt; 2 unit day ( anamnesis ) Consumption illicit drug ( anamnesis ) Having give blood within last month , willing make blood donation one month follow end study Subject expect comply study procedure , include consume test product Currently participate participate another clinical trial last month prior begin study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Medium Chain Triglycerides</keyword>
	<keyword>Medium Chain Triglycerides metabolite</keyword>
	<keyword>Peptamen 1.5</keyword>
</DOC>